Antibodies to SARS-CoV-2 and risk of past or future sick leave

The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered sick lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillner, Joakim, Elfström, K. Miriam, Blomqvist, Jonas, Eklund, Carina, Lagheden, Camilla, Nordqvist-Kleppe, Sara, Hellström, Cecilia, Olofsson, Jennie, Andersson, Eni, Jernbom Falk, August, Bergström, Sofia, Hultin, Emilie, Pin, Elisa, Månberg, Anna, Nilsson, Peter, Hedhammar, My, Hober, Sophia, Mattsson, Johan, Mühr, Laila Sara Arroyo, Conneryd Lundgren, Kalle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933367/
https://www.ncbi.nlm.nih.gov/pubmed/33664279
http://dx.doi.org/10.1038/s41598-021-84356-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933367/
https://www.ncbi.nlm.nih.gov/pubmed/33664279
http://dx.doi.org/10.1038/s41598-021-84356-w

Ejemplares similares